/ 1 0. 1 0 0 2 / m d s. 2 9 3 5 9. nocerebellar ataxia type 3. ann neurol. 2024 ; 95 : 400 – 6. https : / / d39. dengq, tang c, chen z, yuan x, ding z, wang c, et al. o i. o r g / 1 0. 1 0 0 2 / a n a. 2 6 8 2 4. decreased peripheral blood lymphocytes in spinocerebellar 25. du tezenas montcel s, petit e, olubajo t, faber j, lallemant - ataxia type 3 correlate with disease severity. mov disord. 2025. dudek p, bushara k, et al. baseline clinical and blood biomarkers https : / / doi. org / 1 0. 1 0 0 2 / m d s. 3 0 1 8 9. in patients with preataxic and early - stage disease spinocerebellar 40. viswambharan v, thanseem i, vasu mm, poovathinal sa, anitha ataxia 1 and 3. neurology. 2023 ; 100 : e1836 – 48. https : / / doi. org / 1 a. mirnas as biomarkers of neurodegenerative disorders. bio0. 1 2 1 2 / w n l. 0 0 0 0 0 0 0 0 0 0 2 0 7 0 8 8. mark med. 2017 ; 11 : 151 – 67. https : / / doi. org / 1 0. 2 2 1 7 / b m m - 2 0 1 6 26. shen x - n, wu k - m, huang y - y, guo y, huang s - y, zhang y - r, - 0 2 4 2. et al. systematic assessment of plasma biomarkers in spinocer - 41. shi y, huang f, tang b, li j, wang j, shen l, et al. microrna ebellar ataxia. neurobiol dis. 2023 ; 181 : 106112. https : / / doi. org / 1 profiling in the serums of sca3 / mjd patients. int j neurosci. 0. 1 0 1 6 / j. n b d. 2 0 2 3. 1 0 6 1 1 2. 2014 ; 124 : 97 –